Revotar receives new composition-of-matter patent for Bimosiamose in the US
Revotar receives new composition-of-matter patent for Bimosiamose in the US
BERLIN and HENNIGSDORF, GERMANY– -Revotar Biopharmaceuticals AG /Revotar receives new composition-of-matter patent for Bimosiamose in the US. Processed and transmitted by Thomson Reuters ONE.The issuer …